CCL18 and neoplasm: Given the well-established role of M2 macrophages in promoting an immunosuppressive tumor microenvironment, this finding suggests that CCL18 may contribute to lymphoma progression by fostering pro-tumorigenic signaling and impaired antitumor immunity in ABC lymphomas.